AMRX
Amneal Pharmaceuticals, Inc.
19.80$
+2.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -47.3% | +20.2% | +10.1% | +224.4% | -15.8% | +9.3% | -1.7% | -3.6% | -8.6% | +0.8% | +5.1% | |
| – | – | +20.1% | +6.3% | +66.7% | -5.9% | +28.2% | -2.0% | -7.1% | -2.4% | +15.2% | +20.4% | |
| – | – | -55.2% | +171.0% | +187.7% | -29.1% | +125.8% | -27.4% | -89.5% | +252.4% | +20.8% | +181.2% | |
| – | – | -52.0% | +133.8% | +187.7% | -28.6% | +125.2% | -27.8% | -88.8% | +237.2% | +19.9% | +176.5% | |
| – | – | +44.2% | -11.0% | +60.9% | +6.9% | +5.7% | +8.7% | +6.8% | -13.0% | +20.1% | +21.2% | |
| – | – | +13.3% | +6.7% | +61.0% | -16.7% | +28.8% | -0.3% | +8.4% | +9.5% | +5.3% | -1.0% | |
| – | – | +90.2% | +19.5% | +11.8% | +14.0% | -23.0% | +7.6% | -8.6% | – | – | – | |
| – | – | -4.6% | -7.0% | +1,511.8% | -1.6% | +24.6% | +13.4% | +1.0% | 0.0% | -0.2% | -0.3% | |
| – | – | -7.6% | -2.9% | +3,610.8% | -16.4% | -5.7% | -10.6% | -6.1% | -18.8% | -17.7% | -23.1% | |
| – | – | +16.1% | +23.1% | +101.2% | -4.0% | +9.9% | -2.1% | +0.5% | -5.0% | +3.9% | +3.6% | |
| – | – | -5.9% | +31.9% | +86.6% | -0.6% | +23.0% | +0.1% | +11.2% | +12.5% | +33.4% | -22.0% | |
| – | – | -38.0% | +141.9% | -75.7% | +70.2% | +55.5% | -19.9% | +127.3% | +117.5% | +49.5% | -93.7% | |
| – | – | -14.2% | +16.6% | +64.0% | -10.3% | +49.6% | -15.0% | +27.3% | -13.9% | +81.0% | -2.0% | |
| – | – | +91.6% | +66.6% | +94.1% | -0.8% | +4.8% | -2.0% | -3.3% | -6.3% | -10.9% | +18.7% | |
| – | – | – | – | – | -74.1% | +30.7% | +18.8% | -17.2% | -93.4% | -652.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | -39.2% | +10.8% | +3.8% | +12.7% | +2.0% | -0.6% | +16.7% | +75.4% | +5.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.